Molecular Applications Group
This article was originally published in The Gray Sheet
Palo Alto, California-based bioinformatics technology developer raises $9.5 mil. in equity funding to support expansion of the GeneMine product line, which is used by pharmaceutical companies to research gene sequencing databases, predict protein structure, and discover gene function. The firm's software enables determination of proteome function and the validation of novel drug targets. Since 1997, the firm has placed 10 systems worldwide
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.